Short-Term Side Effects and SARS-CoV-2 Infection after COVID-19 Pfizer–BioNTech Vaccine in Children Aged 5–11 Years: An Italian Real-World Study

Vaccination against COVID-19 is the most effective tool to protect both the individual and the community from this potentially life-threatening infectious disease. Data from phase-3 trials showed that two doses of the BNT162b2 vaccine were safe, immunogenic, and effective against COVID-19 in childre...

Descripción completa

Detalles Bibliográficos
Autores principales: Capponi, Martina, Pulvirenti, Federica, Cinicola, Bianca Laura, Brindisi, Giulia, Conti, Maria Giulia, Colaiocco, Giovanni, de Castro, Giovanna, Guido, Cristiana Alessia, Duse, Marzia, Midulla, Fabio, Zicari, Anna Maria, Spalice, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317287/
https://www.ncbi.nlm.nih.gov/pubmed/35891219
http://dx.doi.org/10.3390/vaccines10071056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317287/
https://www.ncbi.nlm.nih.gov/pubmed/35891219
http://dx.doi.org/10.3390/vaccines10071056

Ejemplares similares